Table 7.
Incremental cost-effectiveness ratio for scenario B.
Strategy | Infection averted | Cost | IAR | ACER | ICER |
---|---|---|---|---|---|
Strategy 8: | 1.4524 | 0.0015 | 0.0015 | ||
Strategy 6: | 1.5239 | −0.0078 | |||
Strategy 7: | 1.4506 | 0.0068 | |||
Strategy 5: | 1.5759 | −0.0016 |
Incremental cost-effectiveness ratio for scenario B.
Strategy | Infection averted | Cost | IAR | ACER | ICER |
---|---|---|---|---|---|
Strategy 8: | 1.4524 | 0.0015 | 0.0015 | ||
Strategy 6: | 1.5239 | −0.0078 | |||
Strategy 7: | 1.4506 | 0.0068 | |||
Strategy 5: | 1.5759 | −0.0016 |